Solidus
Data-driven estimates for upfront payments, milestones, and royalties across 12 therapeutic areas of biopharma licensing deals
Oncology Solidus
2025-2026 Market Benchmarks v5.0
Estimated Deal Value
$883M – $1.8B
Upfront: $214M
Est. Deal Value
$883M – $1.8B
Upfront
$214M
Free account — 3 calculations with deal term estimates. Upgrade to Pro for unlimited access, rNPV, Monte Carlo, and partner matching.
Your deal analysis will appear here
- Upfront payment benchmarks
- Comparable deal analysis
- Negotiation playbook